Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person ALK G881D [plasma membrane]
| Class:Id | EntityWithAccessionedSequence:9715260 |
|---|---|
| _displayName | ALK G881D [plasma membrane] |
| _timestamp | 2021-02-17 00:34:25 |
| compartment | [Compartment:876] plasma membrane |
| created | [InstanceEdit:9715264] Rothfels, Karen, 2021-02-17 |
| disease | [Disease:9699595] anaplastic large cell lymphoma |
| endCoordinate | 1620 |
| hasModifiedResidue | [ReplacedResidue:9715214] glycine 881 replaced with L-aspartic acid |
| literatureReference | [LiteratureReference:9715255] Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer |
| name | ALK G881D ALK tyrosine kinase receptor ALK_HUMAN |
| referenceEntity | [ReferenceGeneProduct:49894] UniProt:Q9UM73 ALK [Homo sapiens] |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9715278] R-HSA-9715260.1 |
| startCoordinate | 19 |
| (hasCandidate) | [CandidateSet:9700087] extracellular domain ALK mutants [plasma membrane] [Homo sapiens] |
| (hasComponent) | [Complex:9715313] ALK G881D dimer [plasma membrane] [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by ALK G881D [plasma membrane] (9715260)
